Innovative solutions to
keep your project on course

Site of Absorption Studies

Overview

Site of absorption studies are conducted early in development with different formulations of a given drug to determine which has the highest absorption at distinct locations of the GI track (jejunum, ilium, colon) or which formulation releases drug at the optimal location in the GI track for maximum absorption and bioavailability.

Scientific & PK Considerations

Site of absorption studies rely on pharmacokinetics following release of drug at specific locations of the GI track.  The PK parameters determined from release in areas of the small intestine (jejunum, ilium) or large intestine (colon) are compared and used to evaluate the optimal formulation for additional clinical trials.

When to Execute Site of Absorption Studies in Development Programs

The timing around execution of a site of absorption study depends on multiple factors including interactions with regulatory authorities, funding, investor expectations, exit strategies, and overall clinical development plans to support future studies or de-risk the continued development of a drug.

Explore Our Blog

The Path to IND Part 2: Supporting Clinical Study Design and Dosing

Introduction In part one of this blog series, “The Path to IND Part I: Milestones and Common Roadblocks,” we introduced…

Read More

Former FDA Reviewers Provide Answers to Key Questions: Part 2

Two of Nuventra’s consultants, Gene Williams and Brian Furmanski, spent a combined 23 years working at the FDA. In Part…

Read More
What is Population PK

What is Population Pharmacokinetic (popPK) Analysis?

Population pharmacokinetics (popPK) is the study of variability in drug concentrations within a patient population receiving clinically relevant doses of a…

Read More